Sorrento Therapeutics, Inc. Stock
Stocks
SRNE
US83587F2020
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
OTC Markets
10/09/2026
|
5-day change | 1st Jan Change | ||
| 0.000400 USD | -20.00% |
|
-33.33% | -84.62% |
| 03-18 | Semnur Pharmaceuticals, Inc. Announces CEO Changes, Effective March 13, 2026 | CI |
| 03-18 | Semnur Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 67.15M 57.75M 54.49M 49.64M 92.79M 6.42B 93.63M 649M 250M 3.26B 252M 247M 10.34B | P/E 2021 |
-3.2x | P/E 2022 | -0.65x |
|---|---|---|---|---|---|
| Enterprise Value | 152M 130M 123M 112M 210M 14.5B 211M 1.47B 564M 7.36B 570M 557M 23.36B | EV / Sales 2021 |
29.1x | EV / Sales 2022 | 7.89x |
| Free-Float |
98.65% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -20.00% | ||
| 1 week | -33.33% | ||
| Current month | -20.00% | ||
| 3 months | -60.00% | ||
| 6 months | -84.00% | ||
| Current year | -84.62% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.05 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 8.28 |
| 10 years | 0 | | 19.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 61 | 01/04/2011 |
Scott Schaus
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2022 |
John Waldheim
LAW | General Counsel | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Henry Ji
CHM | Chairman | 61 | 01/08/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -20.00% | -33.33% | -80.00% | -99.83% | 217K | |
| -0.25% | -1.36% | +44.08% | +102.76% | 68.24B | |
| +0.51% | -3.74% | +31.37% | +74.94% | 62.23B | |
| -1.18% | +0.47% | -12.78% | +384.69% | 27.8B | |
| -1.05% | -4.43% | +30.56% | +10.07% | 24.86B | |
| -1.76% | -6.30% | -4.55% | -19.75% | 24.22B | |
| +0.14% | -3.60% | +14.58% | -19.48% | 19.36B | |
| -1.86% | -2.22% | +202.03% | +353.89% | 17.28B | |
| -1.94% | -4.94% | -5.29% | +495.65% | 14.46B | |
| -1.54% | -2.88% | +52.33% | +159.75% | 14.23B | |
| Average | -2.89% | -6.31% | +27.23% | +144.27% | 27.27B | |
| Weighted average by Cap. | -0.61% | -3.10% | +35.56% | +136.87% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 52.9M 45.5M 42.93M 39.11M 73.11M 5.06B 73.77M 511M 197M 2.57B 199M 194M 8.15B | 62.84M 54.04M 50.99M 46.45M 86.83M 6.01B 87.62M 607M 234M 3.05B 236M 231M 9.68B |
| Net income | -428M -368M -348M -317M -592M -40.95B -597M -4.14B -1.59B -20.77B -1.61B -1.57B -65.97B | -573M -493M -465M -423M -792M -54.77B -799M -5.54B -2.13B -27.78B -2.15B -2.1B -88.24B |
| Net Debt | 111M 95.2M 89.82M 81.83M 153M 10.58B 154M 1.07B 412M 5.37B 416M 407M 17.05B | 84.53M 72.69M 68.59M 62.48M 117M 8.08B 118M 817M 314M 4.1B 317M 310M 13.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | $0.000400 | -20.00% | 33,800 |
| 09/09/26 | $0.000500 | +25.00% | 54,942 |
| 08/09/26 | $0.000400 | -33.33% | 129,160 |
| 04/09/26 | $0.000600 | 0.00% | 26,035 |
| 03/09/26 | $0.000600 | 0.00% | 91,492 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SRNE Stock
Select your edition
All financial news and data tailored to specific country editions
